Osteopontin as a multifaceted driver of bone metastasis and drug resistance-Reference-Cited by-同舟云学术

Osteopontin as a multifaceted driver of bone metastasis and drug resistance

Published:2019-06 Issue: Volume:144 Page:235-244
ISSN:1043-6618
Container-title:Pharmacological Research
language:en
Short-container-title:Pharmacological Research

Author:

Pang Xiaocong,Gong Kan,Zhang Xiaodan,Wu Shiliang,Cui Yimin,Qian Bin-Zhi

Funder

National Key R&D Program of China

National Natural Science Foundation

PR China; Beijing Municipal Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology

Reference139 articles.

1. Bone: a fertile soil for Cancer metastasis;Coughlin;Curr. Drug Targets,2017

2. Bone metastasis and the metastatic niche;Ren;J. Mol. Med.,2015

3. Bone cell activity in clinical prostate cancer bone metastasis and its inverse relation to tumor cell androgen receptor activity;Nordstrand;Int. J. Mol. Sci.,2018

4. Identification of bone-derived factors conferring de novo therapeutic resistance in metastatic prostate cancer;Lee;Cancer Res.,2015

5. Heterogeneity of tumor cells in the bone microenvironment: mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer;Futakuchi;Adv. Drug Deliv. Rev.,2016

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pretreatment plasma osteopontin level as a marker of response to curative radiotherapy and hormonal treatment for prostate cancer;Radiotherapy and Oncology;2024-11

2. Si and Zn dual ions upregulate the osteogenic differentiation of mBMSCs: mRNA transcriptomic sequencing analysis;Journal of Materials Science: Materials in Medicine;2024-09-10

3. Exploring Protein-Based Carriers in Drug Delivery: A Review;Pharmaceutics;2024-09-05

4. Review on effects and mechanisms of plant-derived natural products against breast cancer bone metastasis;Heliyon;2024-09

5. Circulating interleukin-8 and osteopontin are promising biomarkers of clinical outcomes in advanced melanoma patients treated with targeted therapy;Journal of Experimental & Clinical Cancer Research;2024-08-15